SEC Form D private-offering filing
AOA DX Inc.
A new SEC Form D private-offering notice from Denver, CO, a $30,582,903 filer-stated offering target in Biotech. The source filing is one click away.
AI powered blood test platform for early detection of ovarian cancer using a proprietary multi omic biomarker technology called GlycoLocate.
Filed 2025-10-15Filed to raise $30,582,903First money in 2025-10-01Raised so far $8,085,364HQ (as filed) Denver, COSector Biotech ✓Stage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Website verified aoadx.com↗Named in the filing 6 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.